Aranesp anaemia drug being administered

Aranesp anaemia drug being administered

M715/0644 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 34.9MB

Downloadable file size: 1.7MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Aranesp anaemia drug being administered to a 70 year old male cancer patient. The syringe contains the anaemia drug darbepoetin alfa, which is marketed as Aranesp. The drug is a synthetic protein that stimulates the production of red blood cells (erythrocytes). It is used to treat anaemias (deficiencies in red blood cells) caused by chronic renal failure or, as in this case, chemotherapy treatment. An increase in red blood cells can cause thickening of the blood and increase the likelihood of several conditions, including high blood pressure, blood clots and heart attack. Aranesp is also used illegally in sport to increase an athlete's blood oxygen levels and therefore enhance performance.

Release details: Model release available. Property release not required.

Keywords: 70, 70s, administering, adult, anaemia, anaemias, anemia, aranesp, cancer patient, caucasian, chemotherapy treatment, chronic renal failure, clinical, darbepoetin alfa, disposable, doctor, doping, dose, drug, elderly, equipment, erythropoiesis, haematology, hand, healthcare, hematology, human, injecting, male, man, medical, medicine, nurse, old, patient, people, performance-enhancing drug, person, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, protein, seventies, seventy, single use, sport, sports, synthetic, syringe, treatment, white

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.